AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ORTHOCELL LTD

1.325

-0.015-1.12%

Volume:865.66K

Turnover:1.17M

Market Cap:320.62M

PE:-83.13

High:1.395

Open:1.375

Low:1.315

Close:1.340

Loading ...

Overview Company News Filings

Company Profile

Company Name:

ORTHOCELL LTD

Exchange:

ASX

Establishment Date:

2006

Employees:

- -

Office Location:

Building 191,Murdoch University,90 South Street,Murdoch,Western Australia,Australia

Website:

http://www.orthocell.com.au

Zip Code:

6150

Phone:

Fax:

61 8 9360 2899

Introduction:

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and related technologies for the repair and regeneration of human tendon, bone, nerve, and cartilage defects in Australia. The company's principal products include CelGro, a naturally derived collagen medical device for soft tissue repair that is under clinical trials for use as an augment to the surgical repair of tendons, peripheral nerves, bones, and articular cartilage; and Ortho-ATI, an autologous tenocyte implantation for chronic treatment degenerative tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation for the treatment of symptomatic defects of the articulating cartilage of the joints, primarily in the knee and ankle. Orthocell Limited was founded in 2006 and is based in Murdoch, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OCC.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OCC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OCC.AU\",,,,,undefined,":{"symbol":"OCC.AU","market":"AU","secType":"STK","nameCN":"ORTHOCELL LTD","latestPrice":1.325,"timestamp":1747116720000,"preClose":1.34,"halted":0,"volume":865662,"delay":0,"nameEN":"ORTHOCELL LTD","floatShares":191252770,"shares":241976241,"eps":-0.015939,"marketStatus":"Not Yet Opened","change":-0.015,"latestTime":"05-13 16:12:00 AEST","open":1.375,"high":1.395,"low":1.315,"amount":1170450,"amplitude":0.059701,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.015939,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1747180800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":1.34,"openAndCloseTimeList":[[1747094400000,1747116000000]],"volumeRatio":0.6419335289866571,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OCC.AU\",,,,,undefined,":{"symbol":"OCC.AU","floatShares":191252770,"roa":"-20.32%","roe":"-29.77%","lyrEps":-0.035547,"volumeRatio":0.6419335289866571,"shares":241976241,"dividePrice":0,"high":1.395,"amplitude":0.059701,"preClose":1.34,"low":1.315,"week52Low":0.35,"pbRate":"16.33","psRate":"50.77","week52High":1.79,"institutionHeld":0,"latestPrice":1.325,"eps":-0.015939,"divideRate":0,"volume":865662,"delay":0,"ttmEps":-0.015939,"open":1.375,"prevYearClose":1.355,"prevWeekClose":1.38,"prevMonthClose":1.595,"prevQuarterClose":1.495,"fiveDayClose":1.55,"twentyDayClose":1.5,"sixtyDayClose":1.565},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":54227224,"yearFounded":2006,"address":"Building 191,Murdoch University,90 South Street,Murdoch,Western Australia,Australia","zipCode":"6150","officePhone":"61 8 9360 2888","officeFax":"61 8 9360 2899"},"stockCompanyDetail":{"websiteUrl":"http://www.orthocell.com.au","stockEarnings":[{"period":"1week","weight":-0.1452},{"period":"1month","weight":-0.0669},{"period":"3month","weight":-0.197},{"period":"6month","weight":1.0703},{"period":"1year","weight":2.3974},{"period":"ytd","weight":-0.0221}],"compareEarnings":[{"period":"1week","weight":-0.003},{"period":"1month","weight":0.0514},{"period":"3month","weight":0.0345},{"period":"6month","weight":0.1389},{"period":"1year","weight":0.1401},{"period":"ytd","weight":0.0986}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and related technologies for the repair and regeneration of human tendon, bone, nerve, and cartilage defects in Australia. The company's principal products include CelGro, a naturally derived collagen medical device for soft tissue repair that is under clinical trials for use as an augment to the surgical repair of tendons, peripheral nerves, bones, and articular cartilage; and Ortho-ATI, an autologous tenocyte implantation for chronic treatment degenerative tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation for the treatment of symptomatic defects of the articulating cartilage of the joints, primarily in the knee and ankle. Orthocell Limited was founded in 2006 and is based in Murdoch, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.181818,"avgChangeRate":-0.082645},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.01619},{"month":3,"riseRate":0.636364,"avgChangeRate":0.050392},{"month":4,"riseRate":0.363636,"avgChangeRate":0.23703},{"month":5,"riseRate":0.3,"avgChangeRate":-0.043303},{"month":6,"riseRate":0.7,"avgChangeRate":0.168586},{"month":7,"riseRate":0.2,"avgChangeRate":-0.054059},{"month":8,"riseRate":0.545455,"avgChangeRate":0.044752},{"month":9,"riseRate":0.545455,"avgChangeRate":0.07255},{"month":10,"riseRate":0.545455,"avgChangeRate":0.057037},{"month":11,"riseRate":0.272727,"avgChangeRate":-0.018998},{"month":12,"riseRate":0.454545,"avgChangeRate":0.030491}],"exchange":"ASX","name":"ORTHOCELL LTD","nameEN":"ORTHOCELL LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OCC.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OCC.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OCC.AU\",market:\"AU\",,,undefined,":[]}}